Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 2Uveal Melanoma 1Smoking Cessation 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Inflammation 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

epigallocatechin gallate 2XENP 1595 2Etanercept 2Ascorbic Acid 2salicylsalicylic acid 1microcrystalline cellulose 1ginger extract 1dapagliflozin 1cytisine 1Tablets 1Sulindac 1Spirometry 1Specimen Handling 1Sodium Salicylate 1Radiotherapy, Conformal 1Pregabalin 1Omeprazole 1Losartan 1Ketorolac 1Interleukin 1 Receptor Antagonist Protein 1Infliximab 1Hematologic Tests 1Diet Therapy 1Atorvastatin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Inflammation × Diet Therapy × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡